Skyrizi — Nutrient Depletion & Health Patterns
Also known as: Risankizumab-rzaa
Drug Class: Biologic Immunosuppressant (IL-23 Inhibitor)
Biologic medication that selectively inhibits interleukin-23 (IL-23), used to treat moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease by targeting specific immune pathways.
Common Side Effects of Skyrizi
- Upper respiratory infections
- Headache
- Fatigue
- Injection site reactions
- Fungal infections
- TB reactivation risk
Key Drug Interactions — Skyrizi
Skyrizi has 3 documented drug-drug interactions in WePattern's Pattern Health Intelligence database. Key interactions include:
- Live vaccines (AVOID)
- Other immunosuppressants
- Immunizations
Frequently Asked Questions
Does Skyrizi deplete nutrients?
Skyrizi use may affect nutrient balance. WePattern's Knowledge Graph maps documented depletion patterns from peer-reviewed clinical data.
What nutrients does Skyrizi deplete?
WePattern maps the documented nutrient connections for Skyrizi drawn from clinical literature.
What are the side effects of Skyrizi?
Common side effects associated with Skyrizi include: Upper respiratory infections; Headache; Fatigue; Injection site reactions; Fungal infections.